Cite
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
MLA
Niederwieser, Dietger, et al. “Different Treatment Strategies versus a Common Standard Arm (CSA) in Patients with Newly Diagnosed AML over the Age of 60 Years: A Randomized German Inter-Group Study.” Annals of Hematology, vol. 102, no. 3, Mar. 2023, pp. 547–61. EBSCOhost, https://doi.org/10.1007/s00277-023-05087-8.
APA
Niederwieser, D., Lang, T., Krahl, R., Heinicke, T., Maschmeyer, G., Al-Ali, H. K., Schwind, S., Jentzsch, M., Cross, M., Kahl, C., Wolf, H.-H., Sayer, H., Schulze, A., Dreger, P., Hegenbart, U., Krämer, A., Junghanss, C., Mügge, L.-O., Hähling, D., & Hirt, C. (2023). Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. Annals of Hematology, 102(3), 547–561. https://doi.org/10.1007/s00277-023-05087-8
Chicago
Niederwieser, Dietger, Thomas Lang, Rainer Krahl, Thomas Heinicke, Georg Maschmeyer, Haifa Kathrin Al-Ali, Sebastian Schwind, et al. 2023. “Different Treatment Strategies versus a Common Standard Arm (CSA) in Patients with Newly Diagnosed AML over the Age of 60 Years: A Randomized German Inter-Group Study.” Annals of Hematology 102 (3): 547–61. doi:10.1007/s00277-023-05087-8.